Medication info
Enpidapa Tablet 10mg (Dapagliflozin Propanediol Hydrate)

Enpidapa Tablet 10mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
28 tablets/box [14 tablets/PTP×2]
Approval status
Active

MFDS item code 202204478 · Approved 2022.12.13 · Insurance code 669908220

Summary

Main use
Improves glycemic control in type 2 diabetes
Who takes it
Adults · Children
Adult dose
Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for both monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improves glycemic control in type 2 diabetes

  • Type 2 diabetes
  • poor blood sugar control
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used in conjunction with diet and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with other treatments. It is particularly used in patients with cardiovascular diseases or risk factors among those whose blood sugar is not sufficiently controlled, and the impact on cardiovascular events should be referenced in professional materials. This medication is an important treatment that helps improve blood sugar control and cardiovascular health in patients.

How to take

Adult dose

Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for both monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, individuals allergic to the main ingredient or excipients of this medication, patients with type 1 diabetes or diabetic ketoacidosis, and patients with lactose intolerance or related genetic disorders should not use this medication. Additionally, patients undergoing dialysis should not take this medication. Patients with reduced fluid volume or kidney function issues should use this medication cautiously. This medication may cause blood pressure reduction or worsen kidney function, so patients, especially the elderly or those taking diuretics, require assessment and continuous monitoring by a physician. For patients with significantly impaired kidney function, blood sugar control effects may be diminished, which is not recommended. While taking this medication, various side effects may occur. The most common side effect is genital infection, which may occur more frequently in women. Additionally, reports of hypoglycemia, fluid volume reduction, diabetic ketoacidosis, urinary tract infections, and changes in kidney function have been documented. If abnormal symptoms appear, immediate consultation with healthcare providers is necessary. In particular, ketoacidosis may occur even if blood sugar levels are not high, so if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing occur, rapid examination and treatment are required. Moreover, if pain, swelling, or redness occurs around the perineum, immediate treatment is necessary due to the possibility of serious perineal necrosis. This medication may increase the risk of hypoglycemia when used with hypoglycemic drugs such as insulin or sulfonylureas, so dose adjustments for these drugs may be necessary. Additionally, combining with diuretics may elevate the risk of dehydration or hypotension, necessitating caution. Pregnant or nursing women are advised not to use this medication, and if pregnancy is confirmed, the use should be discontinued immediately. The safety for children has not been established. There is no specific antidote for overdose; therefore, appropriate treatment should be given based on symptoms, and it is not known whether dialysis is effective in removing this medication from the body. Finally, this medication does not significantly affect driving or machine operation abilities, but caution is necessary when there is a risk of hypoglycemia. The medication should be kept out of the reach of children and stored in its original container.

Side effects

vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine at the beginning of treatment, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, sensory disturbances, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, alanine aminotransferase increase, aspartate aminotransferase increase, decreased appetite, somnolence, taste disturbances, nasopharyngitis, upper respiratory tract infection, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like syndrome, vaginal discharge, menstrual irregularities, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, avoid storing it in too hot or too cold environments, ideally at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP×2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.